Am J Perinatol 2006; 23(4): 201-204
DOI: 10.1055/s-2006-934090
Copyright © 2006 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Spontaneous Version Following Preterm Premature Rupture of Membranes

Linda Fonseca1 , Manju Monga1
  • 1Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Texas-Houston Health Science Center, Houston, Texas
Further Information

Publication History

Publication Date:
04 April 2006 (online)

ABSTRACT

Our objective was to determine the rate of spontaneous version following preterm premature rupture of membranes (PPROM). Medical charts over a 4-year period were reviewed. All women with PPROM and singleton gestation between 24 and 34 weeks gestation were included; 65 patients met the inclusion criteria. By ultrasound on admission, 48 were cephalic 16 were breech, and one was transverse lie. Mean amniotic fluid index on admission was 5.1 ± 4.8 cm (standard deviation) and was not associated with fetal presentation at delivery. Spontaneous version from cephalic presentation at admission to noncephalic presentation at delivery occurred in one pregnancy (2.2%). Spontaneous version from noncephalic presentation at admission to cephalic presentation at delivery occurred in three pregnancies (17.6%; p = 0.05). Among women with noncephalic presentation at delivery (n = 15), 73.3% had a cesarean, compared with 23.4% of those with cephalic presentation at delivery (p < 0.05). Spontaneous version, particularly from cephalic to noncephalic presentation, is unlikely following PPROM.

REFERENCES

  • 1 Ventura S J, Martin J A, Curtin S C, Mathews T J. Report of final natality statistics, 1995. Monthly vital statistics report; Vol. 45, No. 11, suppl. Hyattsville, MD; National Center for Health Statistics 1997
  • 2 Mercer B M. Preterm premature rupture of membranes: diagnosis and management.  Clin Perinatal. 2004;  31 765-782
  • 3 Mercer B M, Arheart K L. Antimicrobial therapy in expectant management of preterm premature rupture of the membranes.  Lancet. 1995;  346 1271-1279
  • 4 Hillier S L, Martius J, Krohn M, Kiviat N, Holmes K K, Eschenbach D A. A case-control study of chorioamnionitis infection and histologic chorioamnionitis in prematurity.  N Engl J Med. 1988;  319 972-978
  • 5 Gunn G C, Mishell D R, Morton D G. Premature rupture of the fetal membranes: a review.  Am J Obstet Gynecol. 1970;  106 469-482
  • 6 Morales W J. The effect of chorioamnionitis on the developmental outcome of preterm infants at one year.  Obstet Gynecol. 1987;  70 183-186
  • 7 Garite T J, Freeman R K. Chorioamnionitis in the preterm gestation.  Obstet Gynecol. 1982;  59 539-545
  • 8 Mercer B M, Moretti M L, Prevost R R, Sibai B M. Erythromycin therapy in preterm premature rupture of the membranes: a prospective, randomized trial of 220 patients.  Am J Obstet Gynecol. 1992;  166 794-802
  • 9 Simpson G F, Harbert Jr G M. Use of β-methasone in management of preterm gestation with preterm premature rupture of membranes.  Obstet Gynecol. 1985;  66 168-175
  • 10 Vintzileos A M, Campbell W A, Nochimson D J, Weinbaum P J. Preterm premature rupture of the membranes: a risk factor for the development of abruption placentae.  Am J Obstet Gynecol. 1987;  156 1230-1238
  • 11 Gonen R, Hannah M E, Milligan J E. Does prolonged preterm premature rupture of the membranes predispose to abruption placentae?.  Obstet Gynecol. 1989;  74 347-350
  • 12 Scheer K, Nubar J. Variation of fetal presentation with gestational age.  Am J Obstet Gynecol. 1976;  125 269-270
  • 13 Phelan J P, Ahn M O, Smith C V, Rutherford S E, Anderson S E. Amniotic fluid index measurements during pregnancy.  J Reprod Med. 1987;  32 601-604
  • 14 Rutherford S E, Smith C V, Phelan J P, Kawakami K, Ahn M O. Four quadrant assessment of amniotic fluid volume: interobserver and intraobserver variation.  J Reprod Med. 1987;  32 587-589
  • 15 National Institutes of Health . National Institutes of Health Consensus Development Conference Statement: Effect of corticosteroids for fetal maturation on perinatal outcomes, February 28-March, 1994.  Am J Obstet Gynecol. 1995;  173 246-252
  • 16 Mercer B M, Maiodovnik M, Thurnau G R et al.. Antibiotics therapy for reduction of infant morbidity after preterm premature rupture of the membranes: a randomized controlled trial.  JAMA. 1997;  278 989-995
  • 17 Sherer D M, Spong C Y, Salafia C M. Residual amniotic fluid volume in preterm rupture of membranes: association with fetal presentation and incidence of clinical and histologic evidence of infection.  Am J Perinatol. 1997;  14 125-128
  • 18 Sival D A, Visser G GHA, Prechtl H FR. Does reduction of amniotic fluid affect fetal movements?.  Early Hum Dev. 1990;  23 233-246

Linda FonsecaM.D. 

Division of Maternal Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Texas, Health Science Center Houston

6431 Fannin, 3.604, Houston, TX 77030

    >